DK0480949T4 - Fremstilling af virusvaccine - Google Patents

Fremstilling af virusvaccine

Info

Publication number
DK0480949T4
DK0480949T4 DK90909595T DK90909595T DK0480949T4 DK 0480949 T4 DK0480949 T4 DK 0480949T4 DK 90909595 T DK90909595 T DK 90909595T DK 90909595 T DK90909595 T DK 90909595T DK 0480949 T4 DK0480949 T4 DK 0480949T4
Authority
DK
Denmark
Prior art keywords
virus
preparation
envelope glycoproteins
virus vaccine
isolating
Prior art date
Application number
DK90909595T
Other languages
English (en)
Other versions
DK0480949T3 (da
Inventor
Mary Elizabeth Ewasyshyn
Barry Ian Caplan
Anne-Marie Bonneau
Michel Henri Klein
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10659282&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0480949(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Publication of DK0480949T3 publication Critical patent/DK0480949T3/da
Application granted granted Critical
Publication of DK0480949T4 publication Critical patent/DK0480949T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK90909595T 1989-06-29 1990-06-28 Fremstilling af virusvaccine DK0480949T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898914968A GB8914968D0 (en) 1989-06-29 1989-06-29 Production of virus and purification of viral envelope proteins for vaccine use

Publications (2)

Publication Number Publication Date
DK0480949T3 DK0480949T3 (da) 1995-12-18
DK0480949T4 true DK0480949T4 (da) 2004-12-06

Family

ID=10659282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909595T DK0480949T4 (da) 1989-06-29 1990-06-28 Fremstilling af virusvaccine

Country Status (10)

Country Link
US (2) US6455050B1 (da)
EP (1) EP0480949B2 (da)
JP (1) JP2599503B2 (da)
AT (1) ATE130198T1 (da)
CA (1) CA2056437C (da)
DE (1) DE69023648T3 (da)
DK (1) DK0480949T4 (da)
ES (1) ES2078971T5 (da)
GB (1) GB8914968D0 (da)
WO (1) WO1991000104A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407182A (pt) 1993-08-06 1996-09-17 Connaught Lab Composição imunogênica processo de preparo de composição não-imunopotencializadora imunogênica processo para determinar a presença de anticorpos estojo para diagnóstico para determinar a presença de anticorpos e virus sincicial respiratório humano inativado purificado
US7223410B1 (en) 1994-08-05 2007-05-29 Sanofi Pasteur Limited Inactivated respiratory syncytial viral vaccines
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
PT784486E (pt) * 1994-10-05 2006-07-31 Univ Vanderbilt Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US6165774A (en) * 1995-09-22 2000-12-26 Connaught Laboratories Limited Parainfluenza virus glycoproteins and vaccines
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
CN1678345B (zh) 2002-04-26 2013-09-11 米迪缪尼有限公司 制备流感病毒的多质粒系统
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
CA2807534A1 (en) 2003-02-25 2005-02-17 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
EP1697521B1 (en) 2003-12-23 2010-06-02 MedImmune, LLC Multi plasmid system for the production of influenza virus
CA2690196A1 (en) 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
ES2987238T3 (es) * 2008-12-09 2024-11-14 Novavax Inc Proteínas F del RSV modificadas y métodos de su uso
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
SG184833A1 (en) 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
CN114617959A (zh) 2015-09-03 2022-06-14 诺瓦瓦克斯股份有限公司 具有改进的稳定性和免疫原性的疫苗组合物
CN111148509A (zh) 2017-07-24 2020-05-12 诺瓦瓦克斯股份有限公司 治疗呼吸系统疾病的方法和组合物
USD1096318S1 (en) * 2023-11-29 2025-10-07 Miir Holdings, Llc Cup

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
WO1989005823A1 (en) * 1987-12-23 1989-06-29 The Upjohn Company Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
US5169628A (en) * 1988-04-22 1992-12-08 The Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3

Also Published As

Publication number Publication date
EP0480949A1 (en) 1992-04-22
US6306637B1 (en) 2001-10-23
DE69023648T2 (de) 1996-05-02
CA2056437C (en) 1996-02-06
ES2078971T3 (es) 1996-01-01
CA2056437A1 (en) 1990-12-30
ATE130198T1 (de) 1995-12-15
WO1991000104A1 (en) 1991-01-10
JPH04502410A (ja) 1992-05-07
EP0480949B1 (en) 1995-11-15
DE69023648D1 (de) 1995-12-21
DK0480949T3 (da) 1995-12-18
JP2599503B2 (ja) 1997-04-09
DE69023648T3 (de) 2005-02-03
EP0480949B2 (en) 2004-08-04
US6455050B1 (en) 2002-09-24
ES2078971T5 (es) 2005-03-16
GB8914968D0 (en) 1989-08-23

Similar Documents

Publication Publication Date Title
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DE69635907D1 (de) Neuartige nicht pyrogene bakterienstämme und ihre verwendung
NO304381B1 (no) FremgangsmÕte for fremstilling av hepatitt C-virus (HCV) og anvendelse derav i en immunoanalysemetode
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
DK1007061T3 (da) Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater
NO893149D0 (no) Fremgangsmaate til mikrobiologisk fremstilling av humant serumalbumin og andre heterologe proteiner fra gjaer.
DE69535018D1 (de) Papillomavirus vakzine
ES2075440T3 (es) Vacuna contra la hepatitis b.
IT8621106A1 (it) Vettore ad espressione e secrezione in lieviti, utile per la preparazione di proteine eterologhe
ATE171471T1 (de) Isolierte virale proteine als cytokinantagonisten
PT1118619E (pt) Metodo para identificar agentes activos contra o vhc utilizando as coordenadas estruturais da protease do virus da hepatite c
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
DE69232906D1 (de) Detektion des Hepatis-C Virus.
UA35639C2 (uk) Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
AU2567888A (en) Hiv peptides and methods for detection of hiv
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
FI924746A7 (fi) Kohydrolyysimenetelmä uusien uutteiden valmistamiseksi hiiva- ja ei-hi ivaproteiineista
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
OA09653A (en) Rubella peptides
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
RU93043621A (ru) Способы получения гликопротеинов нсv, способ очистки, аналитический набор, способ выявления нсv, способ элиминации нсv, способ индукции иммунитета, гликопротеины, иммунореагенты
EP0888046A4 (en) METHOD FOR PROTEIN PRODUCTION BY MEANS OF A MITOCHONDRIAL TRANSLATION SYSTEM.
ES8801959A1 (es) Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida